Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
MPLT Insider Trading and Fund Holdings (MapLight Therapeutics, Inc.) · https://wallstpal.com/stock/mplt/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
StockCIK 1770069

MapLight Therapeutics, Inc. (MPLT): Insider Trades and Fund Holdings

In the past 12 months, MapLight Therapeutics, Inc. insiders reported 1 open-market purchase worth $50.1M and 7 sales worth $1.26M; 1 of the sales were reported as made under a 10b5-1 trading plan.

1Insider buys, 12 months
$50.1MBought by insiders, 12 months
$1.26MSold by insiders, 12 months
1Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144) and fund moves in the past year, newest first.

  1. Oct 15, 2026Insider saleCEO Christopher A. Kroeger sold $595,423
  2. Oct 15, 2026Insider saleChief Medical Officer Erin Pennock Foff sold $124,068
  3. Oct 15, 2026Insider saleChief Discovery Officer Anatol Kreitzer sold $96,024
  4. Oct 15, 2026Insider saleChief Scientific Officer James Woodruff Lillie sold $93,025
  5. Oct 15, 2026Insider saleCFO Jonathan Gillis sold $82,149
  6. Oct 15, 2026Insider saleGeneral Counsel Kristopher Hanson sold $72,882
  7. Oct 15, 2026Planned saleKroeger Christopher A. (officer) filed notice to sell about $575,527 around Oct 15, 2026
  8. Oct 15, 2026Planned saleFoff Erin Pennock (officer) filed notice to sell about $119,923 around Oct 15, 2026
  9. Oct 15, 2026Planned saleROBERT MALENKA (director) filed notice to sell about $115,658 around Oct 15, 2026
  10. Oct 15, 2026Planned saleAnatol Kreitzer (officer) filed notice to sell about $97,625 around Oct 15, 2026
  11. Oct 15, 2026Planned saleLillie James Woodruff (officer) filed notice to sell about $89,917 around Oct 15, 2026
  12. Oct 15, 2026Planned saleGILLIS JONATHAN (officer) filed notice to sell about $79,404 around Oct 15, 2026
  13. Oct 15, 2026Planned saleHanson Kristopher (officer) filed notice to sell about $70,446 around Oct 15, 2026
  14. Sep 16, 2026Insider saleGeneral Counsel Kristopher Hanson sold $192,660 under a 10b5-1 plan
  15. Sep 16, 2026Planned saleHanson Kristopher (officer) filed notice to sell about $199,429 around Sep 16, 2026
  16. Aug 14, 2026Insider buy10% owner Catalyst4, Inc. bought $50.1 million
  17. Jun 30, 2026FundRenaissance Technologies opened a position in Q2 2026 (13F filed Aug 13, 2026)

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 16, 2026.

Recent MPLT insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Oct 16Oct 15Christopher A. KroegerCEOCEO▼ SELL73,6918.08$595K−5.8%Form 4 ↗
Oct 16Oct 15Erin Pennock FoffChief Medical OfficerChief Medical Officer▼ SELL15,3558.08$124K−4.9%Form 4 ↗
Oct 16Oct 15Anatol KreitzerChief Discovery OfficerChief Discovery Officer▼ SELL12,2487.84$96K−6.8%Form 4 ↗
Oct 16Oct 15James Woodruff LillieChief Scientific OfficerChief Scientific Officer▼ SELL11,5138.08$93K−5.5%Form 4 ↗
Oct 16Oct 15Jonathan GillisCFOCFO▼ SELL10,1678.08$82K−6.7%Form 4 ↗
Oct 16Oct 15Kristopher HansonGeneral CounselGeneral Counsel▼ SELL9,0208.08$73K−6.6%Form 4 ↗
Sep 18Sep 16Kristopher HansonGeneral CounselGeneral Counsel▼ SELL10b5-116,50911.67$193K−11%Form 4 ↗
Aug 18Aug 14Catalyst4, Inc.10% owner10% owner (ind.)▲ BUY4,400,00011.38$50.1M+21%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Christopher A. KroegerCEO0$01$595KOct 16, 2026
Erin Pennock FoffChief Medical Officer0$01$124KOct 16, 2026
Anatol KreitzerChief Discovery Officer0$01$96KOct 16, 2026
James Woodruff LillieChief Scientific Officer0$01$93KOct 16, 2026
Jonathan GillisCFO0$01$82KOct 16, 2026
Kristopher HansonGeneral Counsel0$02$266KOct 16, 2026
Catalyst4, Inc.10% owner1$50.1M0$0Aug 18, 2026

Tracked funds that report MPLT

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Renaissance TechnologiesQ2 20266,937$249K0.00%▲ New
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →